ADVERTISEMENT

Departments

Menopausal Health
A New SERM on the Horizon
Baker VL
2008;33:15

Bazedoxifene is a third-generation selective estrogen receptor modulator currently in development as an option for the prevention and treatment of postmenopausal osteoporosis. This review provides a overview of bazedoxifene’s known clinical effects, and offers insight into how this new therapeutic agent may fit into the options available for postmenopausal women in the near future.


ADVERTISEMENT
ADVERTISEMENT

Breaking News

More Headlines